Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities
DNA nanorobots—tiny, self-assembling machines capable of detecting diseases in blood samples within 2–4 hours
The capital was raised via multiple-tenure non-convertible debentures (NCDs) and commercial papers
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
Subscribe To Our Newsletter & Stay Updated
